Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

GPCR-β-arrestin interactions are an emerging field in GPCR drug discovery. Accurate, precise and easy to set up methods are necessary to monitor such interactions in living systems. We show a structural complementation assay to monitor GPCR-β-arrestin interactions in real time living cells, and it can be extended to any GPCR.

Abstract

Interactions between G-protein coupled receptors (GPCRs) and β-arrestins are vital processes with physiological implications of great importance. Currently, the characterization of novel drugs towards their interactions with β-arrestins and other cytosolic proteins is extremely valuable in the field of GPCR drug discovery particularly during the study of GPCR biased agonism. Here, we show the application of a novel structural complementation assay to accurately monitor receptor-β-arrestin interactions in real time living systems. This method is simple, accurate and can be easily extended to any GPCR of interest and also it has the advantage that it overcomes unspecific interactions due to the presence of a low expression promoter present in each vector system. This structural complementation assay provides key features that allow an accurate and precise monitoring of receptor-β-arrestin interactions, making it suitable in the study of biased agonism of any GPCR system as well as GPCR c-terminus ‘phosphorylation codes’ written by different GPCR-kinases (GRKs) and post-translational modifications of arrestins that stabilize or destabilize the receptor-β-arrestin complex.

Introduction

GPCRs represent the target of nearly 35% of current drugs in the market1,2 and a clear understanding of their pharmacology is crucial in the development of novel therapeutic drugs3. One of the key aspects in GPCR drug discovery, particularly during the development of biased agonists is the characterization of novel ligands towards receptor-β-arrestin interactions4 and β-arrestin interactions with other cytosolic proteins such as clathrin5.

It has been documented that β-arrestin dependent signaling....

Protocol

1. Primer design strategy

  1. Design primers to introduce genes of interest into pBiT1.1-C [TK/LgBiT], pBiT2.1-C [TK/SmBiT], pBiT1.1-N [TK/LgBiT] and pBiT2.1-N [TK/SmBiT] Vectors.
  2. Select at least one of these three sites as one of the two unique restriction enzymes needed for directional cloning due to the presence of an in-frame stop codon that divides the multicloning site as shown in Figure 111.
  3. Incorporate nucleotide sequence into the p.......

Representative Results

Using the procedure presented here, interactions between a prototypical GPCR and two β-arrestin isoforms were monitored. Glucagon like peptide receptor (GLP-1r) constructs were made using primers containing NheI and EcoRI enzyme restriction sites and cloned into the vectors pBiT1.1-C [TK/LgBiT] and pBiT2.1-C [TK/SmBiT] while in the case of β-arrestins, two additional vectors were used pBiT1.1-N [TK/LgBiT] and pBiT2.1-N [TK/SmBiT] using enzyme restriction sites BgIII and EcoRI in the case of β-arrestin2 and.......

Discussion

Using the method presented here, interactions between any GPCR and β-arrestin1/2 can be monitored in real time living systems using this GPCR-β-arrestin structural complementation assay. In this regard, we were able to observe differential β-arrestin recruitment between the two β-arrestin isoforms by the GLP-1r (A prototypical Class B GPCR), we also observed a dissociation of the receptor-β-arrestin complex a few minutes after reaching the maximum luminescent signal.

I.......

Acknowledgements

This work was supported by grants from the Research Program (NRF- 2015M3A9E7029172) of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.

....

Materials

NameCompanyCatalog NumberComments
Antibiotics penicillin streptomycinWelgeneLS202-02Penicillin/Streptomycin
Bacterial IncubatorJEIO TechIB-05GIncubator (Air-Jacket), Basic
Cell culture mediumWelgeneLM 001-05DMEM Cell culture medium
Cell culture transfection mediumGibco31985-070Optimem 1X cell culture medium
CO2 IncubatorNUAIRENU5720Direct Heat CO2 Incubator
Digital water bathLab TechLWB-122DDigital water bath lab tech
DNA Polymerase proof readingELPIS BiotechEBT-1011PfU DNA polymerase
DNA purification kitCosmogenetechCMP0112miniprepLaboPass Purificartion Kit Plasmid Mini
DNA Taq PolymeraseEnzynomicsP750nTaq DNA polymerase
Enzyme restriction BglIINew England BiolabsR0144LBglII
Enzyme restriction bufferNew England BiolabsB72045CutSmart 10X Buffer
Enzyme restriction EcoRINew England BiolabsR3101LEcoRI-HF
Enzyme restriction NheINew England BiolabsR01315NheI
Enzyme restriction XhoINew England BiolabsR0146LXhoI
Fetal Bovine SerumGibco Canada12483020Fetal Bovine Serum
Gel/PCR DNA MiniKitReal Biotech CorporationKH23108HiYield Gel/PCR DNA MiniKit
LigaseELPIS BiotechEBT-1025T4 DNA Ligase
Light microscopeOlympusCKX53SFCKX53 Microscope Olympus
lipid transfection reagentInvitrogen11668-019Lipofectamine 2000
LuminometerBiotek/Fisher Scientific12504386Synergy 2 Multi-Mode Microplate Readers
NanoBiT SystemPromegaN2014NanoBiT PPI MCS Starter System
Nanoluciferase substratePromegaN2012Nano-Glo Live Cell assay system
PCR Thermal cyclerEppendorf6336000015Master cycler Nexus SX1
Poly-L-lysineSigma AldrichP4707-50MLPoly-L-lysine solution
Trypsin EDTAGibco25200-056Trysin EDTA 10X
White Cell culture 96 well platesCorning3917Assay Plate 96 well plate

References

  1. Sriram, K., Insel, P. A. GPCRs as targets for approved drugs: How many targets and how many drugs?. Molecular Pharmacology. 93 (4), 251-258 (2018).
  2. Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., Gloriam, D. E.

Explore More Articles

GPCRarrestin1 2Real timeLive cellDrug DiscoveryReceptor PharmacologyPCRCloningRestriction DigestionHigh fidelity DNA PolymeraseOpioid ReceptorsDopamine ReceptorsNeurologyCardiopulmonary Disease

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved